Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1d interaction and killer Ig receptors

Journal of Immunology

Volumn 181, Issue 5, 2008, Pages 3268-3276

  Patterson, Scott ^a   Chaidos, Aristeidis ^a   Neville, David C A ^b   Poggi, Alessandro ^c   Butters, Terry D ^b   Roberts, Irene A G ^a   Karadimitris, Anastasios ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; GLYCOSPHINGOLIPID; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; T LYMPHOCYTE RECEPTOR; ALLOANTIGEN; CD1 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ALLOIMMUNITY; ARTICLE; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; CROSS REACTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE RESPONSE; MOLECULAR RECOGNITION; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; NATURAL KILLER CELL; PROTEIN BINDING;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD1; GLYCOSPHINGOLIPIDS; HUMANS; ISOANTIGENS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES;

EID: 51549113428     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.5.3268     Document Type: Article

References (47)

1. Brigl, M., and M. B. Brenner. 2004. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22: 817-890. (Pubitemid 38680443)
2. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900. (Pubitemid 40563188)
3. Brigl, M., P. van den Elzen, X. Chen, J. H. Meyers, D. Wu, C. H. Wong, F. Reddington, P. A. Illarianov, G. S. Besra, M. B. Brenner, and J. E. Gumperz. 2006. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors. J. Immunol. 176: 3625-3634. (Pubitemid 43364010)
4. Gumperz, J. E., C. Roy, A. Makowska, D. Lum, M. Sugita, T. Podrebarac, Y. Koezuka, S. A. Porcelli, S. Cardell, M. B. Brenner, and S. M. Behar. 2000. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12: 211-221.
5. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
6. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278: 1626-1629. (Pubitemid 27516282)
7. Porcelli, S., C. E. Yockey, M. B. Brenner, and S. P. Balk. 1993. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8-α/βT cells demonstrates preferential use of several V β genes and an invariant TCR α chain. J. Exp. Med. 178: 1-16. (Pubitemid 23173239)
8. Fujii, S., K. Shimizu, C. Smith, L. Bonifaz, and R. M. Steinman. 2003. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198: 267-279. (Pubitemid 36987852)
9. + T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 171: 5140-5147.
10. Vincent, M. S., D. S. Leslie, J. E. Gumperz, X. Xiong, E. P. Grant, and M. B. Brenner. 2002. CD1-dependent dendritic cell instruction. Nat. Immunol. 3: 1163-1168.
11. Hegde, S., X. Chen, J. M. Keaton, F. Reddington, G. S. Besra, and J. E. Gumperz. 2007. NKT cells direct monocytes into a DC differentiation pathway. J. Leukocyte Biol. 81: 1224-1235. (Pubitemid 46702041)
12. + Tregs and NKT cells: regulators regulating regulators. Trends Immunol. 27: 322-327.
13. Godfrey, D. I., H. R. MacDonald, M. Kronenberg, M. J. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4: 231-237.
14. Sonoda, K. H., M. Exley, S. Snapper, S. P. Balk, and J. Stein-Streilein. 1999. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190: 1215-1226.
15. + Vα14 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J. Clin. Invest. 105: 1761-1767.
16. + cells mediates early graft loss of syngeneic transplanted islets. J. Exp. Med. 202: 913-918.
17. Lan, F., D. Zeng, M. Higuchi, J. P. Higgins, and S. Strober. 2003. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells. Biol. Blood Marrow Transplant. 9: 355-363. (Pubitemid 38351806)
18. Zeng, D., F. Lan, P. Hoffmann, and S. Strober. 2004. Suppression of graft-versus-host disease by naturally occurring regulatory T cells. Transplantation 77: S9-S11. (Pubitemid 38114410)
19. Morris, E. S., K. P. Macdonald, V. Rowe, T. Banovic, R. D. Kuns, A. L. Don, H. M. Bofinger, A. C. Burman, S. D. Olver, N. Kienzle, et al. 2005. NKT cell-dependent leukemia eradication following stem cell mobilization with potent GCSF analogs. J. Clin. Invest. 115: 3093-3103.
20. Patterson, S., I. Kotsianidis, A. Almeida, M. Politou, A. Rahemtulla, B. Matthew, R. R. Schmidt, V. Cerundolo, I. A. Roberts, and A. Karadimitris. 2005. Human invariant NKT cells are required for effective in vitro alloresponses. J. Immunol. 175: 5087-5094. (Pubitemid 41456392)
21. Han, M., L. I. Hannick, M. DiBrino, and M. A. Robinson. 1999. Polymorphism of human CD1 genes. Tissue Antigens 54: 122-127.
22. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
23. Vilches, C., and P. Parham. 2002. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20: 217-251. (Pubitemid 34293425)
24. Bashirova, A. A., M. P. Martin, D. W. McVicar, and M. Carrington. 2006. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu. Rev. Genomics Hum. Genet. 7: 277-300. (Pubitemid 44627931)
25. Valiante, N. M., M. Uhrberg, H. G. Shilling, K. Lienert-Weidenbach, K. L. Arnett, A. D'Andrea, J. H. Phillips, L. L. Lanier, and P. Parham. 1997. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7: 739-751.
26. Katz, G., G. Markel, S. Mizrahi, T. I. Arnon, and O. Mandelboim. 2001. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4. J. Immunol. 166: 7260-7267. (Pubitemid 32525600)
27. Stewart, C. A., F. Laugier-Anfossi, F. Vely, X. Saulquin, J. Riedmuller, A. Tisserant, L. Gauthier, F. Romagne, G. Ferracci, F. A. Arosa, et al. 2005. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin- like receptors. Proc. Natl. Acad. Sci. USA 102: 13224-13229.
28. Vales-Gomez, M., H. T. Reyburn, R. A. Erskine, and J. Strominger. 1998. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc. Natl. Acad. Sci. USA 95: 14326-14331. (Pubitemid 28549366)
29. Katz, G., R. Gazit, T. I. Arnon, T. Gonen-Gross, G. Tarcic, G. Markel, R. Gruda, H. Achdout, O. Drize, S. Merims, and O. Mandelboim. 2004. MHC class I-independent recognition of NK-activating receptor KIR2DS4. J. Immunol. 173: 1819-1825. (Pubitemid 38971615)
30. Snyder, M. R., C. M. Weyand, and J. J. Goronzy. 2004. The double life of NK receptors: stimulation or co-stimulation? Trends Immunol. 25: 25-32.
31. Karadimitris, A., S. Gadola, M. Altamirano, D. Brown, A. Woolfson, P. Klenerman, J. L. Chen, Y. Koezuka, I. A. Roberts, D. A. Price, et al. 2001. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc. Natl. Acad. Sci. USA 98: 3294-3298. (Pubitemid 32220839)
32. Moretta, A., A. Poggi, D. Pende, G. Tripodi, A. M. Orengo, N. Pella, R. Augugliaro, C. Bottino, E. Ciccone, and L. Moretta. 1991. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor α/β. J. Exp. Med. 174: 1393-1398.
33. Poggi, A., S. Negrini, M. R. Zocchi, A. M. Massaro, L. Garbarino, S. Lastraioli, L. Gargiulo, L. Luzzatto, and R. Notaro. 2005. Patients with paroxysmal nocturnal hemoglobinuria have a high frequency of peripheralblood T cells expressing activating isoforms of inhibiting superfamily receptors. Blood 106: 2399-2408. (Pubitemid 41510813)
34. Neville, D. C., V. Coquard, D. A. Priestman, D. J. te Vruchte, D. J. Sillence, R. A. Dwek, F. M. Platt, and T. D. Butters. 2004. Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling. Anal. Biochem. 331: 275-282.
35. Gumperz, J. E., S. Miyake, T. Yamamura, and M. B. Brenner. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195: 625-636.
36. Lee, P. T., K. Benlagha, L. Teyton, and A. Bendelac. 2002. Distinct functional lineages of human V(α)24 natural killer T cells. J. Exp. Med. 195: 637-641. (Pubitemid 34461508)
37. - T cells. J. Exp. Med. 186: 109-120.
38. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19: 197-223. (Pubitemid 32368034)
39. -/-) donors. Immunology 119: 338-347.
40. Raulet, D. H., R. E. Vance, and C. W. McMahon. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19: 291-330. (Pubitemid 32368038)
41. + T lymphocytes directed by T-cell receptor type. Immunology 110: 313-321.
42. Chan, H. W., Z. B. Kurago, C. A. Stewart, M. J. Wilson, M. P. Martin, B. E. Mace, M. Carrington, J. Trowsdale, and C. T. Lutz. 2003. DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J. Exp. Med. 197: 245-255.
43. Uhrberg, M., N. M. Valiante, B. P. Shum, H. G. Shilling, K. Lienert-Weidenbach, B. Corliss, D. Tyan, L. L. Lanier, and P. Parham. 1997. Human diversity in killer cell inhibitory receptor genes. Immunity 7: 753-763. (Pubitemid 28064889)
44. Vely, F., M. Peyrat, C. Couedel, J. Morcet, F. Halary, F. Davodeau, F. Romagne, E. Scotet, X. Saulquin, E. Houssaint, et al. 2001. Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements. J. Immunol. 166: 2487-2494. (Pubitemid 32173485)
45. + natural killer T cells activated by α-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells. Immunology 99: 229-234.
46. Poggi, A., N. Pella, L. Morelli, F. Spada, V. Revello, S. Sivori, R. Augugliaro, L. Moretta, and A. Moretta. 1995. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans. Eur. J. Immunol. 25: 369-376.
47. Borrego, F., M. Masilamani, J. Kabat, T. B. Sanni, and J. E. Coligan. 2005. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor. Mol. Immunol. 42: 485-488. (Pubitemid 39655958)